A Vernon-based business that uses âmagic mushroomâ elements for mental health has started in the United States.
Doseology has introduced seven new adaptogenic mushroom products to the US market.
The diversified life sciences company that develops mushroom-based health and wellness solutions will also launch the product line into the Canadian market in the first quarter of 2022.
Doseology’s website says its mission is to “restore mental health by establishing psychedelic-assisted therapy clinics, building an intellectual property library through research on psychedelic compounds,” and developing and selling products. made from brand name functional mushrooms.
He says these can be used for the treatment of depression, PTSD and other mental health disorders.
“Significant research has shown the positive effects of adaptogens in reducing stress, resisting mental fatigue and improving attention span,” a company statement said.
âThe Doseology line combines adaptogens such as ginger, turmeric, yerba mate and several species of mushrooms, with proven functional mushrooms such as lion’s mane, reishi, shiitake, maitake, royal sun, turkey tail and others. These blended formulations provide enhanced health and wellness benefits over single ingredient products. “
The new product line is aimed at the functional mushroom market, which is expected to reach $ 572 billion worldwide by 2028.
The products in the new Doseology line are aimed at different market segments, including mood and depression, attention and focus, sleep, recovery and anxiety.
In preparation for the Canadian launch, Doseology received six natural product number licenses from Health Canada.
The company is currently exploring Canadian distribution channels, which should include Amazon.ca.
âAfter several months of product development, testing and regulatory approvals, we are pleased to finally launch our products in the US market and soon in Canada. By incorporating the nutrient-rich fruiting bodies of functional fungi and natural health-promoting adaptogens, our products have been designed to optimize the user experience, reflecting our commitment to providing high-quality, natural solutions to improve health. physical and mental, âsaid Daniel Vice, CEO and Director of Doseology.
A central part of the company’s mission is to develop and deliver psychedelic treatments to restore mental health. Once the regulatory framework is established, Doseology’s product line will form the basis of psilocybin-based therapies, creating a whole new market and realizing the company’s vision of better mental health and well-being. for millions of people around the world.
Doseology has completed its application to Health Canada to become an “authorized distributor” under the Controlled Drugs and Substances Act (Canada), which would allow the production of psychedelic compounds, including psilocybin and psilocin.